Personal Information
Unternehmen/Arbeitsplatz
Greater Boston Area United States
Beruf
Assoc. Director, Drug substances
Info
- Ph.D. in synthetic organic chemistry, B.S. in chemical engineering.
- 15 years of pharma/biotech industry experience in both drug discovery and development settings.
- A goal-oriented problem-solver with a proven track record of implementing robust, safe, and economical solutions to challenging chemical problems.
Tags
fviii
hemophilia a
bla
novoeight
fda
inhibitor
hiv
integrase
discovery
raltegravir
drug
Mehr anzeigen
Präsentationen
(2)Gefällt mir
(24)Hit2Lead by example: checkpoint kinase inhibitors
Vladimir Chupakhin
•
Vor 13 Jahren
Stability Of Carbon 14 Labelled Compounds
seankitson
•
Vor 12 Jahren
A Lifecycle Approach to Process Validation
Institute of Validation Technology
•
Vor 11 Jahren
The development & approval of Novoeight, a case study
Allen Che
•
Vor 9 Jahren
Part 4: New HIV Treatment Pipeline
NAPWA
•
Vor 15 Jahren
BioEntrepreneurship: Intellectual Property: What Do Investors Look For?
MaRS Discovery District
•
Vor 16 Jahren
Towards Personalized Medicine
Michel Dumontier
•
Vor 15 Jahren
Business Models For Biotech Firms
Alberto Onetti
•
Vor 15 Jahren
BioEntrepreneurship: The Business of Biotech
MaRS Discovery District
•
Vor 16 Jahren
Considerations On Biotech And Medtech Fundraising
EstherMM
•
Vor 15 Jahren
The Drug Development Process Kerentech
EstherMM
•
Vor 15 Jahren
Optimizing Preclinical Proof of Concept
MaRS Discovery District
•
Vor 15 Jahren
Canada - China Bio/Pharma Bridge
peterloorits
•
Vor 14 Jahren
Messages and drug master files in hospital e-prescription
Simon Letellier
•
Vor 17 Jahren
Drug Master Files for FDA/CDER
bergerb2
•
Vor 17 Jahren
Toxicology in Drug Development
MaRS Discovery District
•
Vor 16 Jahren
GMP AND cGMP CONSIDERATIONS
Prof. Dr. Basavaraj Nanjwade
•
Vor 15 Jahren
How to Draft a Patent
MaRS Discovery District
•
Vor 14 Jahren
Traditional Chinese Medicine
Fieldgarodie
•
Vor 15 Jahren
Regulatory Guidelines For Preclinical And Clinical Validation of Traditional Medicines
Prof. Dr. Basavaraj Nanjwade
•
Vor 15 Jahren
Drug Discovery New Drug Development Process
Prof. Dr. Basavaraj Nanjwade
•
Vor 15 Jahren
Business Butterflies: The Power Of Social Media
Lara McCulloch-Carter
•
Vor 14 Jahren
Drug Discovery - The Origin of New Chemical Entity Pharmaceuticals
MaRS Discovery District
•
Vor 16 Jahren
Introduction To Drug Discovery
ubio Biotechnology Systems Pvt Ltd
•
Vor 16 Jahren
Personal Information
Unternehmen/Arbeitsplatz
Greater Boston Area United States
Beruf
Assoc. Director, Drug substances
Info
- Ph.D. in synthetic organic chemistry, B.S. in chemical engineering.
- 15 years of pharma/biotech industry experience in both drug discovery and development settings.
- A goal-oriented problem-solver with a proven track record of implementing robust, safe, and economical solutions to challenging chemical problems.
Tags
fviii
hemophilia a
bla
novoeight
fda
inhibitor
hiv
integrase
discovery
raltegravir
drug
Mehr anzeigen